CD40LG and neoplasm: The OS analysis (Supplementary Figure S3A and B) in patients with initial (I and II) and advanced (III and IV) tumor stages showed a worse survival curve in the group of patients with tumors in an advanced stage and low expression of CD40 and CD40L.